| Medical and Health Sciences | Lifetime | 16 | DK 1 | 100.00 |
| Biological Sciences | Lifetime | 811 | DK 9 | 99.90 |
| Medical and Health Sciences | 2021-2025 | 107 | DK 2 | 99.98 |
| Biological Sciences | 2021-2025 | 376 | DK 5 | 99.60 |
| Surgery | Lifetime | 2 | DK 1 | 100.00 |
| Epidemiology | Lifetime | 5 | DK 1 | 99.99 |
| Cardiology and Cardiovascular Medicine | Lifetime | 138 | DK 3 | 99.84 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 69 | DK 3 | 99.78 |
| Immunology | Lifetime | 186 | DK 2 | 99.58 |
| Molecular Biology | Lifetime | 848 | DK 14 | 99.55 |
| Cancer Research | Lifetime | 172 | DK 3 | 99.05 |
| Internal Medicine | Lifetime | 77 | DK 2 | 98.44 |
| Genetics | Lifetime | 772 | DK 8 | 98.10 |
| Hematology | Lifetime | 307 | DK 3 | 98.18 |
| Rheumatology | Lifetime | 777 | DK 11 | 96.01 |
| Surgery | 2021-2025 | 10 | DK 2 | 99.95 |
| Immunology | 2021-2025 | 108 | DK 1 | 97.85 |
| Molecular Biology | 2021-2025 | 445 | DK 6 | 97.75 |
| Epidemiology | 2021-2025 | 385 | DK 8 | 96.79 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 437 | DK 9 | 94.39 |
| Oncology | 2021-2025 | 854 | DK 8 | 85.50 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 1 | DK 1 | 100.00 |
| Lipoproteins and Cardiovascular Health | Lifetime | 1 | DK 1 | 100.00 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 2 | DK 1 | 99.99 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 3 | DK 2 | 99.98 |
| Cardiovascular Disease and Adiposity | Lifetime | 4 | DK 1 | 99.95 |
| Cancer, Lipids, and Metabolism | Lifetime | 8 | DK 2 | 99.94 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 23 | DK 1 | 99.88 |
| Inflammasome and immune disorders | Lifetime | 8 | DK 1 | 99.91 |
| Biomarkers in Disease Mechanisms | Lifetime | 3 | DK 1 | 99.67 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 23 | DK 1 | 99.60 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 79 | DK 2 | 99.71 |
| Acute Myocardial Infarction Research | Lifetime | 61 | DK 1 | 99.79 |
| Blood properties and coagulation | Lifetime | 27 | DK 1 | 99.38 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 24 | DK 1 | 98.75 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 63 | DK 2 | 99.62 |
| Protease and Inhibitor Mechanisms | Lifetime | 78 | DK 2 | 99.17 |
| Lipid metabolism and disorders | Lifetime | 46 | DK 3 | 99.16 |
| Cardiovascular Health and Risk Factors | Lifetime | 43 | DK 1 | 99.18 |
| Pharmaceutical Economics and Policy | Lifetime | 58 | DK 1 | 98.76 |
| Peripheral Artery Disease Management | Lifetime | 150 | DK 2 | 98.80 |
| Genetic Associations and Epidemiology | Lifetime | 145 | DK 2 | 99.06 |
| Blood Pressure and Hypertension Studies | Lifetime | 468 | DK 6 | 98.66 |
| Inflammatory mediators and NSAID effects | Lifetime | 380 | DK 6 | 97.65 |
| Folate and B Vitamins Research | Lifetime | 444 | DK 11 | 96.73 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 965 | DK 21 | 97.86 |
| Nutrition, Genetics, and Disease | Lifetime | 334 | DK 11 | 96.13 |
| Hormonal Regulation and Hypertension | Lifetime | 999 | DK 7 | 96.42 |
| Cardiac Fibrosis and Remodeling | Lifetime | 360 | DK 1 | 95.20 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 239 | DK 12 | 95.24 |
| IL-33, ST2, and ILC Pathways | Lifetime | 509 | DK 4 | 95.42 |
| Vitamin C and Antioxidants Research | Lifetime | 511 | DK 12 | 93.98 |
| Cardiac Health and Mental Health | Lifetime | 960 | DK 17 | 94.55 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 919 | DK 8 | 94.24 |
| Health and Medical Research Impacts | Lifetime | 551 | DK 2 | 90.96 |
| Menopause: Health Impacts and Treatments | Lifetime | 734 | DK 12 | 89.31 |
| Sodium Intake and Health | Lifetime | 823 | DK 7 | 89.55 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 2 | DK 1 | 99.87 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 3 | DK 1 | 99.59 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 9 | DK 2 | 99.85 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 11 | DK 2 | 99.70 |
| Inflammasome and immune disorders | 2021-2025 | 10 | DK 1 | 99.08 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 21 | DK 1 | 89.28 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 164 | DK 1 | 85.77 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 702 | DK 11 | 86.54 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 518 | DK 3 | 74.01 |
| Fatty Acid Research and Health | 2021-2025 | 963 | DK 12 | 67.21 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 847 | DK 4 | 52.26 |